Insulinomaearly symptoms The C-peptide level is a crucial biomarker in the diagnosis of insulinoma, a rare tumor of the pancreas that secretes excess insulin. When blood glucose levels are low, an elevated C-peptide level, alongside a high insulin level, strongly suggests endogenous hyperinsulinemia, a hallmark of insulinoma. This diagnostic pathway is essential for identifying the underlying cause of hypoglycemia and initiating appropriate treatment.
C-peptide is a byproduct of insulin production. When the pancreas produces insulin, it also produces an equal amount of C-peptide作者：F Shafi·2025—This case report aims to present a rare instance of insulinoma, presenting with weight loss, neuroglycopenic symptoms, and normal levels of insulin and C- .... Measuring C-peptide levels in the blood or urine provides an indirect yet reliable indicator of how much insulin the body is producing.The diagnosis of aninsulinomais usually made biochemically with low blood glucose, elevated insulin, proinsulin, andC-peptide levels, and confirmed by ... In healthy individuals, C-peptide levels fluctuate with insulin production, typically being lower in a fasted state and rising after a meal.
However, in the context of insulinoma, the pancreatic beta cells within the tumor continuously produce insulin, leading to persistently elevated C-peptide levels. This elevation occurs even when blood glucose is low, a situation that would normally suppress insulin production in a healthy pancreas.A case of low serum insulin levels in a patient with insulinoma in Therefore, a high C-peptide level in conjunction with hypoglycemia is a key indicator that the body is producing too much insulin autonomously, a characteristic of insulinoma.
The interpretation of C-peptide levels in suspected insulinoma is complex and often involves several diagnostic criteria and tests. While specific numerical thresholds can vary slightly between laboratories and clinical guidelines, several key points emerge from diagnostic research:
* Elevated Levels: Generally, C-peptide levels of ≥ 0.6 ng/mL (0作者：F mikael Chandra·2024—Research has found that measurement of insulin andC-peptideduring OGTT may help diagnoseinsulinoma. We aimed to assess the diagnostic value ....2 nmol/L) or ≥ 200 pmol/L are considered elevated and suggestive of insulinoma, especially when accompanied by hypoglycemia. Some sources cite levels of ≥ 2.5 ng/mL as particularly indicative. During a prolonged fast, C-peptide values greater than or equal to 0.20 nmol/L at the end of the fast are significantLab Test: C Peptide, Insulin C Peptide (Blood) Level.
* Normal Fasting Range: For context, normal fasting C-peptide plasma concentrations typically range from 0.9 to 1.8 ng/mL.
* Concomitant with Hypoglycemia: The most significant finding is a high C-peptide level occurring concurrently with low blood glucose (hypoglycemia). This combination is a strong signal that an insulin-producing tumor is presentInsulinoma presenting with normal insulin and c-peptide ....
* Distinguishing from Other Conditions: Elevated C-peptide levels can also be seen in other conditions causing endogenous hyperinsulinemia, such as sulfonylurea intoxication. However, the pattern and magnitude of elevation, combined with other tests, help differentiate theseA case of low serum insulin levels in a patient with insulinoma in. For instance, a high C-peptide level with a low blood glucose level strongly points towards insulinoma or factitious insulin use.作者：SK Venugopal·2023·被引用次数：25—The normal physiological C-peptide plasma concentration in a fasted state is0.9 to 1.8 ng/ml.[1] A high level could indicate insulin resistance ...
* Proinsulin Levels: Elevated proinsulin levels, often alongside high C-peptide, further support the diagnosis of insulinoma. Proinsulin is the precursor to insulin and C-peptide2025年10月23日—Insulin level >3 mcIU/mL (usually >6 mcIU/mL);C-peptide ≥0.6 ng/mL2, 3. Testing for urinary sulfonylurea helps rule out factitious ....
Diagnosing insulinoma often involves a multi-pronged approach, with C-peptide measurements playing a central role.
* Prolonged Fasting Test: This is a critical diagnostic toolA Systematic Review of the Accuracy of Insulin and C .... Patients are monitored while fasting, and blood samples are drawn periodically to measure glucose, insulin, and C-peptide levelsC-peptide during the prolonged fast in insulinoma. In individuals with insulinoma, hypoglycemia develops, accompanied by inappropriately high insulin and C-peptide levels. Research indicates that C-peptide levels at the end of a prolonged fast are particularly useful.
* Oral Glucose Tolerance Test (OGTT): While less definitive than a fasting test for insulinoma, measuring insulin and C-peptide levels during an OGTT can sometimes aid in diagnosis, particularly in assessing the body's response to glucose.Insulinoma presenting with normal insulin and c-peptide ...
* Insulin/C-peptide Molar Ratio: In some cases, the ratio of insulin to C-peptide can provide clues. For instance, an insulin/C-peptide molar ratio greater than 1 might suggest exogenous insulin administration, whereas a ratio less than 1 is more consistent with insulinoma2021年2月10日—This unique case ofinsulinomaillustrates the diagnostic challenge of symptomatic hypoglycemia with elevated insulinlevelsand seemingly discordant normalc-peptide..
* Ruling Out Exogenous Insulin Use: C-peptide levels are typically low or undetectable in individuals who inject themselves with insulin (surreptitious insulin use), as their body is not producing its own insulin. This is a crucial distinction, as high insulin levels without a corresponding high C-peptide level suggest external insulin administration.2021年2月10日—This unique case ofinsulinomaillustrates the diagnostic challenge of symptomatic hypoglycemia with elevated insulinlevelsand seemingly discordant normalc-peptide.
* Challenges in Diagnosis: While C-peptide is a valuable marker, there can be rare cases of insulinoma presenting with normal or even low C-peptide levels, posing diagnostic challenges. These situations may require more sophisticated testing or imaging to confirm the diagnosis.
Beyond C-peptide, other biochemical markers are assessed in the workup for insulinoma:
* Insulin Levels: Elevated insulin levels are a direct indicator of hyperinsulinemia. However, as mentioned, insulin levels alone can be misleading due to exogenous administration.
* Proinsulin Levels: High proinsulin concentrations, often exceeding 25% or even up to 90% of immunoreactive insulin levels, are highly suggestive of insulinoma.
* Beta-hydroxybutyrate Levels: These are often measured to assess ketone bodies.Insulinoma - Endocrine and Metabolic Disorders In insulinoma, beta-hydroxybutyrate levels may be low (eA high level of C-peptide with a low blood glucose levelmay mean that an insulin-producing tumour of the pancreas (insulinoma) is present. Or it may mean that ....g2012年11月19日—elevated levels of proinsulin and C peptide suggest insulinoma. •Insulin levels generally decline in patients with type 1 diabetes mellitus.., ≤ 2.7 mmol/L) due to the suppressive effect of high insulin on lipolysis.
* Sulfonylurea Screening: Testing for the presence of sulfonylureas in the plasma or urine is important to rule out factitious hypoglycemia caused by these medications, which stimulate insulin release.
In summary, the C-peptide level is a cornerstone in the biochemical investigation of insulinoma. When interpreted in conjunction with blood glucose, insulin, and other relevant markers, particularly during a prolonged fast, it provides critical insights into the presence of an insulin-producing tumor and guides the subsequent diagnostic and therapeutic journey.Insulinoma: Practice Essentials, Background, ...
Join the newsletter to receive news, updates, new products and freebies in your inbox.